Correlation Between Bio Path and Freeline Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bio Path and Freeline Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Path and Freeline Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Path Holdings and Freeline Therapeutics Holdings, you can compare the effects of market volatilities on Bio Path and Freeline Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Path with a short position of Freeline Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Path and Freeline Therapeutics.
Diversification Opportunities for Bio Path and Freeline Therapeutics
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Bio and Freeline is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and Freeline Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Freeline Therapeutics and Bio Path is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Path Holdings are associated (or correlated) with Freeline Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Freeline Therapeutics has no effect on the direction of Bio Path i.e., Bio Path and Freeline Therapeutics go up and down completely randomly.
Pair Corralation between Bio Path and Freeline Therapeutics
If you would invest 431.00 in Freeline Therapeutics Holdings on September 18, 2024 and sell it today you would earn a total of 0.00 from holding Freeline Therapeutics Holdings or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 1.59% |
Values | Daily Returns |
Bio Path Holdings vs. Freeline Therapeutics Holdings
Performance |
Timeline |
Bio Path Holdings |
Freeline Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Bio Path and Freeline Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bio Path and Freeline Therapeutics
The main advantage of trading using opposite Bio Path and Freeline Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Path position performs unexpectedly, Freeline Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Freeline Therapeutics will offset losses from the drop in Freeline Therapeutics' long position.Bio Path vs. Puma Biotechnology | Bio Path vs. Iovance Biotherapeutics | Bio Path vs. Syndax Pharmaceuticals | Bio Path vs. Protagonist Therapeutics |
Freeline Therapeutics vs. Cns Pharmaceuticals | Freeline Therapeutics vs. ZyVersa Therapeutics | Freeline Therapeutics vs. Immix Biopharma | Freeline Therapeutics vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |